Test to prevent genetic diseases

Genetic diseases are disorders that originate from an alteration in a gene. There are many genetic diseases and more are being discovered every day. It is not possible to cause or prevent a genetic alteration, but there are tests and studies to prevent the appearance of these diseases.

Cancer is fundamentally a genetically based problem. According to the International Agency for Research on Cancer (IARC), by 2030 cancer will be the leading cause of death worldwide. It is estimated that in Spain, one in two men and one in three women will be diagnosed with cancer in their lifetime.

However, preventing new cases of cancer and increasing the life expectancy of patients is also possible thanks to prevention and early detection strategies. Thus, early detection through cancer prevention studies is one of the fundamental pillars for the control of hereditary cancer. At Cerba Internacional we have several genetic studies for the detection of mutations in the gene or genes involved in each case.

Panel of 27 genes
The Hereditary Cancer Panel is a study that analyzes 27 genes that increase the susceptibility to hereditary cancer. This susceptibility is transmitted among family members according to different inheritance patterns.

The identification of families and individuals with possible hereditary cancers is important, as their members could benefit from effective measures not only in early detection, but also in tumor prevention. Our technology allows us to adapt to the needs of the specialist physician, being able to add or modify the genes that are considered most appropriate at any given time.

Genetic disease carrier panel
Thinking about starting a family?
CarrierSafe® is the test that will provide the necessary information for your peace of mind.

Thanks to CarrierSafe®, future parents will know if they are carriers of a genetic mutation in the same gene, with a 25% risk of transmitting it. It is estimated that each person is a carrier of up to 7 pathogenic variants that can lead to a serious genetic disease in the offspring.

Non Invasive Prenatal Test
Our BBSafe® test is a non-invasive prenatal test that only requires a maternal blood collection, so it does not pose any risk to the baby or the mother.

We analyze the DNA of the placenta found in the mother’s blood, which allows us to detect the probability of suffering different genetic anomalies. Our study can be performed from the 10th week of pregnancy (12 in twin pregnancies).

We have three BBSAFE® options: Standard, Plus and Advanced. If you want more information about this test click on the button.